Work

Faculty Opinions recommendation of Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.

Year: 2016

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.726070352.793519935

Author: John R Couchman

Institution: University of Copenhagen

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4251894404

Cites:

Cited by:

Related to: 10